| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |